Docoh
Loading...

CMMB Chemomab Therapeutics

News

From Benzinga Pro
12 Health Care Stocks Moving In Wednesday's Intraday Session
22 Dec 21
Movers
Gainers
55 Biggest Movers From Yesterday
22 Dec 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Reliance Global Group, Inc. (NASDAQ: RELI) shares jumped 78.7% to close at $5.45 on Tuesday after gaining around 6% on Monday.
12 Health Care Stocks Moving In Thursday's After-Market Session
16 Dec 21
Movers
12 Health Care Stocks Moving In Thursday's After-Market Session
9 Dec 21
Movers
Gainers
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
7 Dec 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Aegis Capital Initiates Coverage On Chemomab Therapeutics with Buy Rating, Announces Price Target of $30
7 Dec 21
News, Price Target, Initiation, Analyst Ratings
Aegis Capital analyst Nathan Weinstein initiates coverage on Chemomab Therapeutics (NASDAQ:CMMB) with a Buy rating and announces Price Target of $30.
12 Health Care Stocks Moving In Monday's Pre-Market Session
6 Dec 21
Pre-Market Outlook, Markets, Movers
12 Health Care Stocks Moving In Friday's Pre-Market Session
3 Dec 21
Pre-Market Outlook, Markets, Movers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
2 Dec 21
Pre-Market Outlook, Markets, Movers
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
2 Dec 21
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
FDA Signs Off Chemomab's Lead Candidate Mid-Stage Study In Bile Duct Disease
2 Dec 21
Biotech, Long Ideas, News, Health Care, FDA, Movers, Trading Ideas, General
The FDA has cleared Chemomab Therapeutics Ltd's (NASDAQ:
Chemomab Announced FDA Clearance of Its IND Application for CM-101, a First-In-Class CCL24 Neutralizing Antibody for the Treatment of Primary Sclerosing Cholangitis
2 Dec 21
News, FDA
Chemomab Therapeutics, Ltd. (NASDAQ: CMMB) (Chemomab), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today announced that the U.S.
54 Biggest Movers From Yesterday
22 Oct 21
News, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares climbed 356.8% to close at $45.50 on Thursday following an announcement the company will merge with Trump Media & Technology Group.
12 Health Care Stocks Moving In Thursday's After-Market Session
21 Oct 21
Movers
Gainers
12 Health Care Stocks Moving In Thursday's Intraday Session
21 Oct 21
Intraday Update, Markets, Movers
38 Stocks Moving In Thursday's Mid-Day Session
21 Oct 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares jumped 132.3% to $23.14 following an announcement the company will merge with Trump Media & Technology Group.
12 Health Care Stocks Moving In Thursday's Pre-Market Session
21 Oct 21
Pre-Market Outlook, Markets, Movers
23 Stocks Moving in Thursday's Pre-Market Session
21 Oct 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) rose 34.9% to $13.44 in pre-market trading after announcement of a proposed merger with Trump Media & Technology Group.

Press releases

From Benzinga Pro
Chemomab Therapeutics Names Jack Lawler Vice President of Global Clinical Development Operations
4 Jan 22
Press Releases
TEL AVIV, Israel, Jan. 4, 2022 /PRNewswire/ -- Chemomab Therapeutics Ltd. (NASDAQ:CMMB), (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic
Chemomab to Participate in LifeSci Partners Annual Corporate Access Event and H.C. Wainwright BioConnect 2022 Healthcare Conference
20 Dec 21
Press Releases
TEL AVIV, Israel, Dec. 20, 2021 /PRNewswire/ -- Chemomab Therapeutics, Ltd. (NASDAQ:CMMB) (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for
Chemomab Therapeutics Announces Expected Appointment of Dale R. Pfost as Chairman of the Board
16 Dec 21
Press Releases
TEL AVIV, Israel, Dec. 16, 2021 /PRNewswire/ -- Chemomab Therapeutics Ltd. (NASDAQ:CMMB), (Chemomab) a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic
Chemomab Therapeutics Names David M. Weiner, MD as Interim Chief Medical Officer
3 Dec 21
Press Releases
TEL AVIV, Israel, Dec. 3, 2021 /PRNewswire/ -- Chemomab Therapeutics Ltd. (NASDAQ:CMMB), (Chemomab) a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrotic and
Chemomab Announces FDA Clearance of Its IND Application for CM-101, a First-In-Class CCL24 Neutralizing Antibody for the Treatment of Primary Sclerosing Cholangitis
2 Dec 21
Press Releases
TEL AVIV, Israel, Dec. 2, 2021 /PRNewswire/ -- Chemomab Therapeutics, Ltd. (NASDAQ:CMMB) (Chemomab), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrotic and
Chemomab Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
12 Nov 21
Earnings, Press Releases
TEL AVIV, Israel, Nov. 12, 2021 /PRNewswire/ -- Chemomab Therapeutics, Ltd. (NASDAQ:CMMB) (Chemomab), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrotic and
Chemomab Announces Poster Presentation at AASLD's The Liver Meeting® 2021
10 Nov 21
Press Releases
TEL AVIV, Israel, Nov. 10, 2021 /PRNewswire/ -- Chemomab Therapeutics, Ltd. (NASDAQ:CMMB) (Chemomab), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrotic and
Chemomab to Present at Stifel 2021 Virtual Healthcare Conference
9 Nov 21
Press Releases
TEL AVIV, Israel, Nov. 9, 2021 /PRNewswire/ -- Chemomab Therapeutics, Ltd. (NASDAQ:CMMB) (Chemomab), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrotic and
Chemomab Therapeutics Names Donald R. Marvin Chief Financial Officer, Executive Vice President and Chief Operating Officer
8 Nov 21
Press Releases
TEL AVIV, Israel, Nov. 8, 2021 /PRNewswire/ -- Chemomab Therapeutics Ltd. (NASDAQ:CMMB), (Chemomab) a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrotic and
Chemomab Therapeutics Hosting Key Opinion Leader Webinar on Systemic Sclerosis
26 Oct 21
Press Releases
TEL AVIV, Israel, Oct. 26, 2021 /PRNewswire/ -- Chemomab Therapeutics Ltd. (NASDAQ:CMMB) ("Chemomab"), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for